Data sheds light on targeting of NF-κB human (host) transcription factor that can reduce the effect of SARS-CoV-2 viral attack, and also provides molecular insights into the action of various currently studied drugs on the above chosen receptor that canopen up vistas for potential therapeutics discovery against COVID-19. Here, NFKB1 is linked to COVID-19.